FOLLICULAR LYMPHOMA
Clinical trials for FOLLICULAR LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new FOLLICULAR LYMPHOMA trials appear
Sign up with your email to follow new studies for FOLLICULAR LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Promising combo for tough lymphoma hits early hurdle
Disease control TerminatedThis early-phase trial tested a combination of two drugs, tazemetostat and venetoclax, in people with Non-Hodgkin lymphoma that had come back or stopped responding to treatment. The main goals were to find the safest dose and understand side effects. Only 3 people took part befor…
Matched conditions: FOLLICULAR LYMPHOMA
Phase: PHASE1 • Sponsor: Weill Medical College of Cornell University • Aim: Disease control
Last updated May 26, 2026 06:55 UTC
-
Cord blood transplant shows promise for tough blood cancers
Disease control TerminatedThis study looked at using umbilical cord blood transplants after strong chemotherapy and radiation to treat various blood cancers like leukemia and lymphoma. It included 200 people and aimed to see how many survived one year after the transplant. The approach is intense and mean…
Matched conditions: FOLLICULAR LYMPHOMA
Phase: NA • Sponsor: Masonic Cancer Center, University of Minnesota • Aim: Disease control
Last updated May 26, 2026 04:38 UTC
-
Immune-boosting drug tested in untreated lymphoma patients
Disease control TerminatedThis study tested the drug pembrolizumab in 9 people with untreated B-cell non-Hodgkin lymphoma. The goal was to see if the drug helps the immune system shrink or control the cancer. The trial was stopped early, so results are limited.
Matched conditions: FOLLICULAR LYMPHOMA
Phase: PHASE2 • Sponsor: University of Washington • Aim: Disease control
Last updated May 18, 2026 12:11 UTC
-
Lymphoma drug combo shows promise in early trial
Disease control TerminatedThis study tested a combination of two drugs, umbralisib and rituximab, as the first treatment for people with follicular lymphoma or marginal zone lymphoma. The goal was to see how many patients had their cancer completely disappear. The study was stopped early and included 18 a…
Matched conditions: FOLLICULAR LYMPHOMA
Phase: PHASE2 • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated Apr 24, 2026 16:19 UTC